Qube Holdings Limited (ASX: QUB) has given a key update on its proposed acquisition of Rubik Australia Pty Limited. The deal was first publicised in a Scheme Implementation Deed dated 16 February 2026.
The proposed acquisition would see Rubik Australia take 100 per cent of the Qube stakes. The company has since incurred expenses to proceed with the transaction, given the regulatory and contractual conditions that have to be satisfied.
Today, Qube claims to have made several critical strides. The advances enable the company to stick to its timetable ahead of the June shareholder meetings.
Qube remains on schedule for shareholder voting as takeover approvals progress. [Courtesy: Capital Brief]
Qube Scheme Of Arrangement Explained For Investors
The Qube scheme of arrangement explained involves the acquisition of Australia’s major logistics operator by Rubik Australia Pty Limited. The transaction remains subject to regulatory approvals, contractual requirements and shareholder support.
A scheme of arrangement is a court-approved process commonly used for large corporate acquisitions in Australia. It requires shareholder approval before implementation.
For Qube investors, the proposal offers a combination of cash payments and dividend benefits. The package is structured to give certainty to the shareholders and enable them to reap the benefits of the transaction.
The new update indicates that things are moving along pretty much as they should. This has attracted more attention from the market in the lead-up to the upcoming shareholder meetings.
What Regulatory Approvals have been obtained?
Qube reported positive developments across several approval pathways. These milestones represent significant progress towards completion.
Key updates include:
- Approval received from the PNG Independent Consumer and Competition Commission.
- The majority of required third-party consents or waivers have been obtained.
- Several contractual conditions continue advancing.
- Remaining regulatory reviews are progressing.
The company noted that some outstanding consents remain subject to conditions. But those needs will be met before the second hearing date, Qube hopes.
One of the most closely-watched parts of the deal remains regulatory approval. When a project is approved successfully, it can be seen as a positive indicator for the project’s completion.
Importance Of ACCC, FIRB, and OIO Decisions
Although things are going well, there are a number of big approvals that have yet to be granted. These include reviews by:
- Australian Competition and Consumer Commission (ACCC)
- Foreign Investment Review Board (FIRB)
- Overseas Investment Office (OIO)
These approvals are required before the scheme can be implemented. Each regulator assesses different aspects of the transaction.
The ACCC focuses on competition impacts. FIRB evaluates foreign investment considerations. The OIO review forms part of broader regulatory requirements linked to the transaction.
Qube stated these approvals continue progressing through the relevant review processes.
Investors continue monitoring ACCC, FIRB and OIO approval outcomes. [Courtesy: My Medical Department]
When Will Qube Shareholders Vote On The Deal?
Qube intends to maintain its existing timetable despite outstanding approvals. The General Scheme Meeting for shareholders (apart from UniSuper) will be held on Tuesday, 16 June 2026 at 11 am Sydney time.
The General Scheme Meeting will be followed directly by the UniSuper Scheme Meeting. These meetings are a crucial part of the acquisition process. The shareholders will be given the chance to vote on whether the proposed transaction should move forward.
The vote will be pivotal in shaping the future of the company. The scheduled dates indicate Qube remains confident regarding the progress achieved so far.
How Could The Special Dividend Increase Shareholder Value?
Alongside the takeover consideration, Qube has outlined plans for a fully franked special dividend. Subject to the scheme becoming effective, the board intends to declare a special dividend of $0.3465 cash per fully paid ordinary share.
Potential benefits include:
- Special dividend of $0.3465 per share.
- Franking credits worth up to $0.1485 per share.
- Additional value for eligible shareholders.
- Fully franked distribution structure.
The company noted that eligibility for franking credits depends on individual tax circumstances.
Qube has also applied to the Australian Taxation Office for a class ruling regarding the tax treatment of the special dividend.
What Is The Total Transaction Consideration?
The total transaction consideration equals $5.20 cash per Qube Share, subject to the scheme becoming effective and the special dividend being declared. The package consists of three separate components. These include:
- Interim Dividend of $0.0535 cash per share.
- Scheme Consideration of $4.80 cash per share.
- Special Dividend of $0.3465 cash per share.
The Interim Dividend was paid on 9 April 2026 to shareholders holding Qube shares on 4 March 2026.
Combined, these payments create the overall value proposition being presented to investors under the proposed transaction.
Why Does The Qube Board Recommend The Scheme?
The Qube Board has unanimously recommended that shareholders vote in favour of the proposal.
This recommendation remains subject to two conditions. First, no Superior Proposal emerges. Second, the Independent Expert continues to conclude the scheme is in shareholders’ best interests.
The board’s support provides a strong endorsement of the transaction.
Qube also confirmed that each board member intends to vote, or cause to be voted, shares they hold or control in favour of the scheme.
For investors, unanimous board backing often strengthens confidence in a proposed corporate transaction.
What Comes Next For Investors?
The Qube scheme of arrangement explained highlights a transaction entering its final stages. Remaining reviews are on track, and Key approvals are in place.
Now, the focus will be on shareholder meetings and regulatory results in the next few weeks.
Any changes to the regulations from ACCC, FIRB, and OIO will be monitored by investors before the implementation can take place.
The Qube transaction really shows that merger and acquisition stuff is still going on across the ASX, where investors keep a close watch on corporate deals and the shareholder value results, kind of how things pan out in the end.
Also Read: Qube Holdings Flags Up to $20M FY26 Earnings Hit from Middle East Conflict and Adverse Weather
FAQs
Q1: What Is The Proposed Value Of The Qube Transaction?
A1: The proposed consideration totals $5.20 cash per Qube Share. It includes dividends and scheme consideration.
Q2: When Will Shareholders Vote On The Scheme?
A2: The General Scheme Meeting will be held on 16 June 2026. The UniSuper meeting follows immediately afterwards.
Q3: What Is The Proposed Special Dividend?
A3: The board intends to declare a fully franked special dividend of $0.3465 per share, subject to conditions.
Q4: Which Approvals Are Still Outstanding?
A4: Approvals from ACCC, FIRB and OIO remain outstanding. Qube said these reviews continue progressing.
Disclaimer
The purpose of this article is only for information and for the sake of informing the public. It is not financial, legal, taxation, or investment advice. Investors are advised to make their own investment decisions and obtain professional advice prior to investing in Qube Holdings, the proposed scheme of arrangement, dividend entitlements, or any associated tax implications.
Source Links
- https://data-api.marketindex.com.au/api/v1/announcements/XASX:QUB:2A1676395/pdf/inline/scheme-update
- https://mfam.com.au/asx-announcements/qub-2026-06-09-qube-announces-second-scheme-update/
Luke Carlino is a seasoned Copywriter, Content Strategist, and Social Media Manager specialising in Mining, Finance, and Business journalism. With more than a decade of industry experience, he brings rigorous editorial standards and commercial acuity to every project.
